Related Experiment Video
Updated: Dec 16, 2025
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Demographic and procedural characteristics in the RECording COurses of vasculaR Diseases (RECCORD) registry - the
Nasser Malyar1, Jürgen Stausberg2, Ralf Langhoff3
1Department of Cardiology I - Coronary and Peripheral Vascular Disease, Heart Failure, University Hospital Muenster, Cardiol, Muenster, Germany.
Insights
The RECcording COurses of vasculaR Diseases (RECCORD) registry shows most endovascular revascularizations (EVR) for peripheral artery disease (PAD) treat claudication. Adjunctive drug-coated balloons and stenting are common, with low complication rates in real-world practice.
Area of Science:
- Vascular Medicine
- Interventional Cardiology
- Public Health
Background:
- The RECcording COurses of vasculaR Diseases (RECCORD) registry was established to collect contemporary real-world data on vascular patient care.
- A significant gap existed in understanding current medical and interventional practices for vascular diseases.
- This study focuses on the initial 1000 patients undergoing endovascular revascularization (EVR) for symptomatic peripheral artery disease (PAD).
Purpose of the Study:
- To report the demographic and procedural characteristics of the first 1000 patients in the RECCORD registry undergoing EVR for symptomatic PAD.
- To analyze the real-world utilization of different EVR techniques and devices.
- To assess the outcomes and complication rates associated with EVR in a large, prospective cohort.
Main Methods:
- RECCORD is a prospective, multicenter, observational, all-comers registry.
- Data collection includes demographics, comorbidities, prior interventions, medications, disease severity (Rutherford category), hemodynamics, and procedural details via a web-based platform.
- Patients undergoing EVR for symptomatic PAD are followed for at least one year.
Main Results:
- The study included 1000 patients (mean age 70 years, 35% female) with 1096 EVR procedures.
- The majority of patients (75%) had non-chronic limb-threatening ischemia (CLTI).
- Femoropopliteal lesions were most common (61.0%). Drug-coated balloons (45.4%) and stenting (57.8%) were frequently used adjunctively. Periprocedural complications occurred in 5.7% of EVR, with pseudoaneurysm being the most common (2.4%).
Conclusions:
- Real-world data from the RECCORD registry indicate that most EVR procedures for PAD are performed in patients with claudication.
- Adjunctive use of drug-coated balloons and stenting are dominant EVR strategies.
- Periprocedural complication rates in this cohort are acceptably low.
Abstract:
Background: The RECcording COurses of vasculaR Diseases (RECCORD) registry established by the German Society of Angiology - Society for Vascular Medicine aimed to address the lack in contemporary real-world data regarding current practice of medical and interventional care in vascular patients. We herein report the demographic and procedural characteristics of the first 1000 patients undergoing endovascular revascularization (EVR) for symptomatic peripheral artery disease (PAD). Patients and methods: RECCORD is an observational, prospective, multicenter, all-comers registry. Only patients undergoing EVR for symptomatic PAD are included and followed up for at least 1 year. Demographic characteristics, comorbidities, previous peripheral vascular interventions, medication, clinical stage of lower extremity artery disease (Rutherford category), hemodynamic parameters, and procedural data including complications are recorded via an entirely web-based platform. Results: Of the first 1000 patients (mean age 70 ± 10 years, 35% female) with 1096 EVR at 1477 vascular segments of the lower extremities, 25.0% were at the stage of chronic limb threatening ischemia (CLTI) and 75.0% at non-CLTI. The femoropopliteal segment was the dominant target lesion site (61.0%), followed by iliac (26.4%) and below-the-knee EVR (10.3%). Only angioplasty was performed in 130 EVR (11.9%), adjunctive drug coated balloons (DCB) in 498 (45.4%), additional stenting in 633 (57.8%). Debulking devices were used in 106 (9.7%) EVR. Clinical (Rutherford categories) and hemodynamic parameters (ankle-brachial-index) as well as secondary preventive medication were significantly improved post EVR. Periprocedural complications occurred in 63 (5.7%) EVR with pseudoaneurysm as the leading complication type in 26 (2.4%) EVR. Conclusions: The baseline data of the first 1000 patients from the RECCORD registry representing the real-world setting illustrate that the majority of EVR are performed in patients with claudication. Adjunctive use of DCB and stenting are the dominant types of EVR, while periprocedural complications are at an acceptable low rate.
More Related Videos
08:05Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
Published on: December 9, 2022
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
Related Concept Videos
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
01:30Peripheral Artery Disease I: Introduction
01:23Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
01:26Varicose Veins II: Diagnostic Studies and Interprofessional Care
01:27Peripheral Artery Disease III: Interprofessional Care
01:19Imaging Studies VII: Vascular Imaging